<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0107245463
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1997
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        PULMICORT0.25MG-ML SINGLE DOSE PLASTIC U
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        BUDESONIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        0.25
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Inhalation use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Nebuliser suspension
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        2
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Ampoule
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        94.4
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="AstraZeneca" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            AstraZeneca
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 354]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            AstraZeneca
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        R03BA02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Pulmicort is used in regular treatment of asthma.<br />Pulmicort relieves and prevents inflammation in the airways caused by asthma. Pulmicort is intended for regular and maintenance use and not for rapid relief of acute asthma conditions. It may take some weeks before you receive the full effect of the treatment.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not use Pulmicort:</strong><br />If you are allergic (hypersensitive) to budesonide or any of the other ingredients of Pulmicort.</p><p><strong>Take special care with Pulmicort:</strong><br />Tell your doctor if you:<br />&bull; have or have had a liver disease or a problem with your liver,&nbsp;</p><p>&bull; have lung tuberculosis (active or inactive),<br />&bull; have a fungal or viral infection in the airways.</p><p>If you switch from cortisone tablets to Pulmicort, your previous allergic symptoms such as a runny nose and eczema may return in certain cases. You may also experience tiredness, headaches, muscle and joint pain and occasionally nausea and vomiting. This is because the total amount of cortisone in the body is reduced when the disease is treated locally in the lungs. These symptoms disappear after you have received treatment for some time.</p><p>You should rinse your mouth out with water after each dosage to minimise the risk of fungal infection in your mouth and throat. Contact your doctor if you get symptoms of a fungal infection.</p><p>In rare cases, in long term treatment with budesonide, growth in children and adolescents may reduce. If your child uses this medicine for a long time, the doctor will usually want to check the child&rsquo;s height regularly.</p><p>You must contact your doctor if your asthma gets worse. This may mean that the dosage needs to be changed or that you need other treatment.</p><p>In an acute asthma attack you must use your fast-acting asthma medicine.</p><p><strong>Using other medicines:</strong><br />Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.<br />Some medicines may affect or be affected by treatment with Pulmicort, for example those containing:<br />&bull; ketoconazole or itraconazole (present in medicines for fungal infections).<br />&bull; saquinavir, indinavir, ritonavir, nelfinavir, amprenavir, lopinavir, fosamprenavir, atazanavir or tipranavir (known as HIV protease inhibitors that are used in HIV).</p><p>Pulmicort Turbuhaler may affect a test that is made to check pituitary function, ACTH simulation test, which may give a false low value.</p><p><strong>Pregnancy and breastfeeding:</strong><br />Experience from usage during pregnancy does not show any increased risk of malformations. However, you must talk to your doctor before using Pulmicort during pregnancy because the severity of the asthma may change and the treatment may need to be adjusted.</p><p>Budesonide is excreted in breast milk. However, no effects on the nursing child are anticipated with therapeutic doses of Pulmicort. Pulmicort can be used during breastfeeding.</p><p>Ask your doctor or pharmacist for advice before taking any medicine.</p><p><strong>Driving and using machines:</strong><br />Pulmicort does not affect your ability to drive a car or use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Asthma:<br />Your doctor will tell you how much to take. This will depend on how severe your asthma is. Your doctor may lower your dose as your asthma improves.<br />&bull; The usual starting dose in adults and children over 12 years is 1 mg to 2 mg ( milligrams) ,twice a day.<br />&bull; Children under 12 years are usually prescribed a lower dose of 0.5 mg to 1 mg, twice a day.</p><p>Always use Pulmicort exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.</p><p>Your doctor prescribes the correct dose for you.<br />The number of doses varies according to the severity of your asthma.<br />You must use Pulmicort regularly, i.e. every day, even if you have no symptoms.</p><p>Pulmicort nebuliser suspension is inhaled via a nebuliser device (= inhaler). When you breathe in through the mouthpiece or the facemask, the medicine follows the inhaled air into your airways. Therefore, it is important to breathe in smoothly and calmly when you take your dose, see &quot;Instructions for use&quot;.</p><p>Instructions for use:<br />Pulmicort nebuliser suspension must only be used in a special inhaler called a nebuliser.</p><p>1. Mix the suspension before use by carefully shaking the single dose unit in a circular motion.<br />2. Hold the single dose unit upright and open by twisting off the wing (see figure).</p><p><img alt="" width="167" height="250" src="data:image/png;base64,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" /></p><p>3. Squeeze out the liquid into the nebuliser chamber.<br />The single dose unit is marked with a line (Pulmicort 0.25 mg/ml and 0.5 mg/ml only). This line indicates a volume of 1 ml when the single dose unit is held upside down.<br />If only 1 ml is to be used, empty the contents until the level of the liquid reaches the indicator line.<br />Store the opened single dose unit away from light.<br />The opened single dose unit must be used within 12 hours.<br />Shake the single dose unit carefully before using the remaining liquid.</p><p>Since the nebuliser unit always contains 2 ml prior to opening, you must dilute it with salt solution (or mix it with another liquid for the nebuliser if your doctor has told you to) if you are to inhale only 1 ml of Pulmicort nebuliser suspension.<br />When you inhale, it is important to breathe in smoothly and calmly via the mouthpiece of the nebuliser. A facemask could be used to make it easier for a child to breathe in.</p><p>Rinse your mouth with water after each dose to get rid of any medicine remaining in your mouth.</p><p>If a facemask is used, make sure that it fits tightly while you are inhaling and wash your face afterwards.</p><p><em>Cleaning:</em><br />Clean the nebuliser chamber and the mouthpiece or facemask in hot water using a mild detergent after each dose. Rinse well and dry.<br />For further information, read the recommendations from the manufacturer of the nebuliser.</p><p>If you take more Pulmicort than you should:<br />If you have taken a larger dose than your doctor has prescribed on one occasion, you will probably not suffer from any side effects. However, if you use a larger dose than your doctor has prescribed over a longer period of time (months), there is a risk that you will suffer from side effects.<br />If you took too great a quantity of medicine or for example a child took the medicine by mistake, contact your doctor, hospital or National Pharmacovigilance Center (NPC) for evaluation of about the risk and advice.</p><p>It is important that you take the dose stated on the label of the packaging or as your doctor has told you. Do not increase or decrease the dose without contacting your doctor.</p><p><strong>If you forget to take Pulmicort:</strong><br />If you have forgotten to take one dose, take the next dose as usual.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Pulmicort can cause side effects, although not everybody gets them.<br /><em>Common (more than 1 in 100 people are affected):</em><br />Irritation of the throat, coughing, hoarseness, fungal infection in the mouth cavity and throat.</p><p><em>Rare (less than 1 in 1000 people are affected):</em><br />Immediate and delayed hypersensitivity reactions such as hives and other skin rashes, contact eczema, angioedema (see below), anaphylactic reactions and corticosteroid effects (see&nbsp;below). Bronchospasm (contraction of the airway muscles), bruising. Depression, restlessness, agitation, behavioural changes (occur mainly in children).</p><p>The following have been reported (occur in an unknown number of users):<br />Glaucoma (increased pressure in the eye), cataract (clouding of the lens in the eye), sleep disturbances, anxiety, aggression, feeling of being very upset and/or irritable.<br />Stop taking Pulmicort and contact your doctor immediately if you get any of the following symptoms of angioedema:<br />&bull; swelling of the face, lips, tongue or throat<br />&bull; difficulty with swallowing<br />&bull; hives and breathing difficulties.</p><p>Irritation of skin on the face has been reported in some cases when the facemask has been used. To avoid this you must always wash your face after using the facemask, see &quot;Instructions for use&quot;.<br />Inhaled corticosteroids can affect the normal production of steroid hormones in your body, particularly if you use high doses for a long time. The effects include:<br />- Changes in bone mineral density (thinning of the bones).<br />- Cataract (clouding of the lens in the eye).<br />- Glaucoma (increased pressure in the eye).<br />- Decreased growth rate in children and adolescents.<br />- An effect on the adrenal gland (a small gland next to the kidney).<br />These effects are much less likely to happen with inhaled corticosteroids than with cortisone tablets.</p><p>If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull; Keep out of the reach and sight of children.<br />&bull; The single dose units must be stored upright and not above 30C.<br />&bull; Store the single dose units in a closed foil envelope. Sensitive to light.<br />&bull; Single dose units in an opened foil envelope should be used within 3 months.<br />&bull; Opened single dose units must be used within 12 hours. Note: If only 1 ml has been used, the remaining volume is not sterile.</p><p>&bull; Do not use Pulmicort after the expiry date which is stated on the package<br />(EXP). The expiry date refers to the last day of that month.<br />&bull; Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull; The active substance is budesonide. One single dose unit (2 ml) contains 0.5 mg or 1 mg budesonide, respectively.<br />&bull; The other ingredients are edetate disodium, sodium chloride, polysorbate 80, citric acid (anhydrous), sodium citrate and water for injection. These ingredients are excipients that help make up the suspension.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Each pack (20 x 2 ml) contains 4 foil envelopes with 5 single dose units containing 2 ml each.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>AstraZeneca AB<br />SE-151 85 S&ouml;dert&auml;lje<br />S&ouml;dert&auml;lje<br />Sweden</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                July 2014
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>يستعمل بولميكورت في العلاج المنتظم للربو.<br />بولميكورت يخفف ويمنع التهاب المجاري الهوائية الذي يسببه الربو. بولميكورت مخصص للاستعمال<br />المنتظم والدائم وليس للتخفيف السريع لحالات الربو الحاد. قد يستغرق الأمر عدة أسابيع قبل أن<br />تحصل على التأثير الكامل للعلاج.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>:لا تستعمل بولميكورت</strong><br />- إذا كانت لديك حساسية )فرط حساسية( تجاه بيدوسونيد أو أي من المكونات الأخرى لعقار<br />بولميكورت.</p><p><strong>:توخّ الحرص الشديد عند تناول عقار بولميكورت&nbsp;<br />:أخبر طبيبك إذا</strong><br />&bull; كنت تعاني أو عانيت من مرض كبدي أو مشكلة في الكبد،<br />&bull; كنت تعاني من السل الرئوي )نشط أو غير نشط(،<br />&bull; كنت تعاني من عدوى فطرية أو فيروسية في المجاري الهوائية.</p><p>إذا بدأت بتناول بولميكورت بدلاً من أقراص الكورتيزون، فقد تشعر مرة أخرى بالأعراض التحسسية<br />السابقة التي كنت تعاني منها مثل رشح الأنف والإكزيما في بعض الحالات. كما قد تعاني من التعب<br />والصداع وألم بالعضلات والمفاصل والغثيان والتقيؤ من حينٍ لآخر. يعود السبب في ذلك إلى أنّ<br />إجمالي كمية الكورتيزون في الجسم تقل عند العلاج بالجرعة موضعيًا في الرئتين. تختفي هذه<br />الأعراض بعد تلقي العلاج لبعض الوقت.</p><p>ينبغي شطف الفم بالماء بعد كل جرعة لخفض خطر الإصابة بعدوى فطرية في الفم والحلق. اتصل<br />بطبيبك إذا شعرت بأعراض الإصابة بعدوى فطرية.</p><p>في حالات نادرة، وفي العلاج على المدى الطويل ببيدوسونيد ، قد يقل النمو لدى الأطفال والمراهقين.<br />إذا تناول طفلك هذا الدواء لفترة طويلة، فسيرغب الطبيب في التحقق من طول الطفل بانتظام.</p><p>يجب عليك الاتصال بالطبيب إذا تفاقمت أعراض الربو. قد يعني ذلك أنه لا بد من تغيير الجرعة أو أنك<br />بحاجة إلى تناول علاج آخر.</p><p>عند حدوث نوبة ربو حادة، يتعيّن عليك تناول الدواء سريع المفعول لعلاج الربو.</p><p><strong>:استخدام أدوية أخرى</strong><br />يرجى أن تخبر طبيبك أو الصيدلي الخاص بك إذا كنت تتناول أو إذا تناولت مؤخرًا أي أدوية أخرى بما في<br />ذلك الأدوية التي حصلت عليها من دون وصفة طبية.</p><p>قد تؤثر بعض الأدوية على العلاج بعقار بولميكورت أو قد تتأثر به، على سبيل المثال تلك الأدوية التي<br />تحتوي على:<br />&bull; كيتوكونازول أو إيتراكونازول )الموجود في الأدوية المخصصة لعلاج حالات العدوى الفطرية(.<br />&bull; ساكينافير أو إندينافير أو ريتونافير أو نيلفينافير أو أمبرينافير أو لوبينافير أو فوزامبرينافير أو أتازانافير<br />&nbsp;أو تيبرانافير )المعروفة كمثبطات البروتياز التي تستخدم في علاج الإيدز</p><p>قد يؤثر بولميكورت تيربوهيلار على أي اختبار يتم إجراؤه للتحقق من الوظيفة النخامية، مثل اختبار</p><p>(ACTH)تحفيز الهرمون النخامي</p><p>والذي قد يعطي قيمة منخفضة خاطئة.</p><p><strong>:الحمل والرضاعة&nbsp;</strong></p><p>لا تشير التجارب التي أجريت عند تناول الدواء أثناء الحمل إلى أي زيادة في خطر حدوث تشوهات.<br />ومع ذلك، يجب أن تتحدثي إلى طبيبك قبل استعمال بولميكورت أثناء الحمل حيث إن حدة الربو قد<br />تتغير وبالتالي قد يحتاج العلاج إلى التعديل.</p><p>يُفرَز البيدوسونيد في حليب الأم. على الرغم من ذلك، لا يُتوقع وجود أي تأثيرات على الرضيع عند<br />استخدام الجرعات العلاجية من بولميكورت. يمكن استعمال بولميكورت أثناء الرضاعة.</p><p>استشيري طبيبك أو الصيدلي الخاص بكِ قبل تناول أي دواء.</p><p><strong>:القيادة واستخدام الآلات</strong></p><p>لا يؤثر بولميكورت على القدرة على القيادة أو استعمال الآلات.<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>:الربو</strong></p><p>سوف يخبرك طبيبك بالجرعة التي تتناولها. هذا يعتمد على مدى حدّة الربو لديك. قد يقلل طبيبك من<br />الجرعة مع تحسن الربو لديك.</p><p>&bull; جرعة البداية المعتادة للبالغين و الأطفال فوق 12 عاماً هي 1 ملجم إلى 2 ملجم) مليجرام (,<br />مرتين يومياً.<br />&bull; الأطفال تحت 12 عاماً عادةً يتم إعطاؤهم جرعة أقل, 0.5 ملجم إلى 1 ملجم, مرتين يومياً.<br />عليك استعمال بولميكورت دائمًا وفقًا لتوجيهات الطبيب. يتعيّن عليك التحقق من طبيبك أو الصيدلي<br />الخاص بك إذا لم تكن متأكّدًا.</p><p>سيصف لك الطبيب الجرعة الصحيحة المناسبة لك.<br />يختلف عدد الجرعات وفقًا لحدة الربو لديك.<br />يجب استعمال بولميكورت بانتظام، أي كل يوم، حتى مع عدم وجود أعراض.</p><p>يتم استنشاق معلق رذّاذ بولميكورت بواسطة جهاز رذّاذ (= جهاز استنشاق). عندما تستنشق من خلال<br />فتحة الفم أو قناع الوجه، يتتبع الدواء الهواء الذي يتم استنشاقه داخل المجاري الهوائية. ولذا، من<br />المهم الاستنشاق بسلاسة وهدوء عند تناول الجرعة، انظر &quot;تعليمات الاستعمال&quot;.</p><p><strong>:تعليمات الاستعمال</strong></p><p>لا يجب استعمال معلق رذّاذ بولميكورت إلا في جهاز استنشاق خاص يسمى رذّاذ.</p><p>1. امزج المعلق قبل الاستعمال عن طريق هز وحدة الجرعة الواحدة بحذر في حركة دائرية.</p><p>2. (أمسك وحدة الجرعة الواحدة في وضع عمودي وافتحها عن طريق لي الذراع (انظر الشكل.</p><p><img alt="" width="167" height="250" src="data:image/png;base64,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" /></p><p>3. إدفع السائل الموجود داخل حجرة الرذّاذ.<br />يتم تحديد وحدة الجرعة الواحدة بخط (بولميكورت 0.25 ملجم/ميلليلتر و 0.5 ملجم/ميلليلتر فقط). يشير<br />هذا الخط إلى حجم قدره 1 ميلليلتر عند الإمساك بوحدة الجرعة الواحدة في وضع مقلوب.<br />إذا أردت استعمال 1 ميلليلتر فقط، فقم بإفراغ المحتويات حتى يصل مستوى السائل إلى خط المؤشر.</p><p>احفظ وحدة الجرعة الواحدة بعيدًا عن الضوء.<br />يجب استعمال محتويات وحدة الجرعة الواحدة المفتوحة في غضون 12 ساعة.<br />يجب خضّ وحدة الجرعة الواحدة بعناية قبل استعمال السائل المتبقي.</p><p>نظرًا لأن وحدة الرذّاذ دائمًا ما تحتوي على 2 ميلليلتر قبل الفتح، يتعيّن عليك تخفيفها بمحلول ملح (أو<br />مزجها بسائل آخر مخصص للرذّاذ إذا أخبرك الطبيب بهذا)&nbsp;إذا توجّب عليك استنشاق 1 ميلليلتر فقط من<br />معلق رذّاذ بولميكورت.</p><p>عند الاستنشاق، من المهم أن تستنشق بسلاسة وهدوء من خلال فتحة فم الرذّاذ. قد يسهّل استعمال<br />قناع وجه عملية الاستنشاق على الطفل.</p><p>اشطف فمك بالماء بعد كل جرعة للتخلص من أي دواء متبقي في فمك.<br />إذا كنت تستخدم قناع وجه، فتأكد من أن القناع منطبق بإحكام أثناء الاستنشاق ثم اغسل وجهك بعد<br />ذلك.</p><p><strong><em>:التنظيف&nbsp;</em></strong><br />يجب تنظيف حجرة الرذّاذ وفتحة الفم أو قناع الوجه بالماء الساخن باستعمال منظف خفيف بعد كل<br />(جرعة. اشطفها (ه) جيدًا ثم جففها(ه.</p><p>لمزيد من المعلومات، اقرأ توصيات الشركة المصنعة للرذّاذ.</p><p><strong>:إذا تناولت جرعة من بولميكورت أكثر مما ينبغي</strong></p><p>إذا تناولت جرعة أكبر من تلك التي وصفها الطبيب لمرة واحدة، فمن المحتمل ألا تعاني من أي آثار<br />جانبية. ومع ذلك، عند استخدام جرعة أكبر من تلك التي وصفها الطبيب على مدار فترة زمنية أطول<br />أشهر)، فلا شك من أنك ستواجه خطر الإصابة بآثار جانبية).</p><p>إذا تناولت كمية كبيرة جدًا من الدواء أو إذا تناول طفل الدواء عن طريق الخطأ على سبيل المثال،</p><p>لتقييم درجة( NPC )فاتصل بالطبيب أو المستشفى أو المركز الوطني للتيقظ والسلامة الدوائية</p><p>الخطورة وطلب النصيحة.</p><p>من المهم أن تتناول الجرعة الموضحة على ملصق العبوة أو وفقًا لما أشار إليه الطبيب. لا تقم بزيادة<br />الجرعة أو تقليلها بدون الاتصال بالطبيب.</p><p><strong>:إذا نسيت تناول بولميكورت&nbsp;</strong></p><p>إذا نسيت تناول جرعة واحدة، فتناول الجرعة التالية كالمعتاد.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>كما هو الحال في جميع الأدوية، قد يتسبّب بولميكورت بحدوث آثار جانبية على الرغم من أنها لا تصيب<br />جميع المستخدمين.</p><p><em>:(شائعة (يتأثر بها أكثر من 1 في 100 شخص</em></p><p>تهيج في الحلق وسعال وبحة في الصوت وعدوى فطرية في تجويف الفم والحلق.</p><p><em>:(نادرة (يتأثر بها أقل من 1 في 1000 شخص</em></p><p>تفاعلات تحسسية فورية ومتأخرة مثل الشرى وحالات الطفح الجلدي الأخرى وإكزيما التماس والوذمة<br />الوعائية (انظر أدناه) والتفاعلات التأقية وتأثيرات الستيرويدات القشرية (انظر أدناه). التشنج القصبي<br />انقباض في عضلات المجاري الهوائية)، رضوض. اكتئاب، قلق، تهيج، تغيرات سلوكية (تحدث غالبًا لدى)<br />.(الأطفال<br />:(تم الإبلاغ عن الأعراض الجانبية التالية (تحدث في عدد مجهول من المستخدمين<br />الجلوكوما (زيادة في ضغط العين)، الكتاراكت(عَتَمة على عدسة العين)، اضطرابات في النوم، قلق،<br />عدوانية، شعور بالاضطراب الشديد و/أو سرعة التهيج.</p><p>:توقف عن تناول بولميكورت واتصل بالطبيب على الفور إذا شعرت بأحد أعراض الوذمة الوعائية التالية</p><p>&bull; تورم الوجه أو الشفتين أو اللسان أو الحلق<br />&bull; صعوبة في البلع<br />&bull; شرى وصعوبات في التنفس.</p><p>تم الإبلاغ عن تهيج في جلد الوجه في بعض الحالات عند استعمال قناع الوجه. لتجنب ذلك، يجب عليك<br />&quot;دائمًا غسل وجهك بعد استعمال قناع الوجه، انظر &quot;تعليمات الاستعمال</p><p>قد تؤثر الكورتيكوستيرويدات المستنشقة على الإنتاج الطبيعي لهرمونات الستيرويدات في الجسم، لا<br />:سيما إذا كنت تتناول جرعات عالية لفترة زمنية طويلة. تتضمن الآثار</p><p>(تغيرات في كثافة معادن العظام (وهن العظام<br />- (الكتاراكت (عَتَمة على عدسة العين<br />- (الجلوكوما (زيادة في ضغط العين<br />- نقص في معدل النمو لدى الأطفال والمراهقين<br />- (تأثير على الغدة الكظرية (غدة صغيرة مجاورة للكلية.<br />يقل احتمال حدوث هذه الآثار عند استخدام الكورتيكوستيرويدات المستنشقة أكثر من أقراص<br />الكورتيزون.</p><p>إذا ازدادت خطورة أي من الآثار الجانبية، أو إذا لاحظت ظهور أي آثار جانبية غير مذكورة في هذه<br />النشرة، فيرجى إعلام طبيبك أو الصيدلي الخاص بك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&bull; احفظ العقار بعيدًا عن متناول الأطفال ورؤيتهم.<br />&bull; يجب تخزين وحدات الجرعة الواحدة في وضع عمودي وفي درجة حرارة لا تزيد عن 30 درجة<br />مئوية.<br />&bull; قم بتخزين وحدات الجرعة الواحدة في مغلف مغلق مصنوع من رقائق الألومنيوم. حسّاسة<br />تجاه الضوء.<br />&bull; يجب استعمال وحدات الجرعة الواحدة المخزنة في مغلف مفتوح مصنوع من رقائق الألومنيوم<br />في غضون 3 أشهر.<br />&bull; يجب استعمال محتويات وحدة الجرعة الواحدة المفتوحة في غضون 12 ساعة. ملاحظة: إذا تم<br />استعمال 1 ميلليلتر فقط، تصبح الكمية المتبقية غير معقمة.<br />&bull; لا تتناول بولميكورت بعد تاريخ انتهاء الصلاحية المدوّن على العبوة. يشير تاريخ انتهاء الصلاحية<br />إلى آخر يوم في الشهر المدوّن.</p><p>لا تتخلص من الأدوية عبر مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي الخاص بك &bull;<br />عن كيفية التخلص من الأدوية التي لم تعد تحتاج إليها. تساعد هذه الإجراءات في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&bull; المادة النشطة هي بيدوسونيد. تحتوي كل وحدة 2 ميلليلتر للجرعة الواحدة على: 0.5 ملجم أو 1<br />ملجم من البيدوسونيد، على التوالي.</p><p>&bull; المكونات الأخرى هي إيديتات الصوديوم وهيدروكسيد الصوديوم وكلوريد الصوديوم وبوليسوربات<br />80 وحمض الليمون (اللامائي)&nbsp;وسيترات الصوديوم وماء الحقن. تساعد هذه المكونات في تصنيع<br />المعلق.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            تحتوي كل عبوة ( 20 × 2 ميلليليتر) على 4 مغلفات مصنوعة من رقائق الألومنيوم بالإضافة إلى 5
وحدات للجرعة الواحدة تحتوي كل جرعة منها على 2 ميلليلتر.
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>AstraZeneca AB<br />SE-151 85 S&ouml;dert&auml;lje<br />S&ouml;dert&auml;lje<br />Sweden</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            يوليو 2014
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Pulmicort, 0.25 mg/ml, nebuliser suspension
Pulmicort, 0.5 mg/ml, nebuliser suspension
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each single-dose unit à 2 ml contains: 0.5 mg or 1 mg budesonide. For excipients see 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Nebuliser suspension.
Whitish suspension in single-dose unit made of plastic.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Bronchial asthma.<br />This pharmaceutical form is indicated for patients who cannot use the spray for inhalation or Turbuhaler for administration of the medical product.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The dosage of Pulmicort is individual. In the case of daily doses up to 1 mg the whole dose may be given in one administration. In the case of higher daily doses the dose is divided into two administrations per day. For children, the highest dose (2 mg per day) should only be administered in case of severe asthma and during a limited period of time.<br />Initially the dosage:<br />When treatment is started, during periods of severe asthma and while reducing or discontinuing oral glucocorticosteroids, the recommended dose of Pulmicort Respules is:<br />Adults( including elderly ): usually 1 &ndash; 2 mg twice daily. In very severe cases the dosage may be further increased.<br />Children 12 years and older: Dosage as for adults.<br />Children 3 months to 12 years: 0.5 &ndash; 1 mg twice daily.<br />Maintenance:<br />The mentenance dose should be individualized and be the lowest dose which keeps the patient symptoms-free.<br />Adults ( including elderly and children 12 years and older ): 0.5 &ndash; 1 mg twice daily.</p><p>Children 3 months to 12 years: 0.25 &ndash; 0.5 mg twice daily.<br />Dosage table:</p><table border="1" cellspacing="1" cellpadding="1"><tbody><tr><td><strong>Dose (mg)</strong></td><td rowspan="1" colspan="2"><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Volume of Pulmicort nebuliser suspension</strong></td></tr><tr><td>&nbsp;</td><td>0.25 mg/ml</td><td>0.5 mg/ml</td></tr><tr><td>0.25</td><td>1 ml*</td><td>-</td></tr><tr><td>0.5</td><td>2 ml</td><td>-</td></tr><tr><td>0.75</td><td>3 ml</td><td>-</td></tr><tr><td>1</td><td>4 ml</td><td>2 ml</td></tr><tr><td>1.5</td><td>-</td><td>3 ml</td></tr><tr><td>2</td><td>-</td><td>4 ml</td></tr></tbody></table><p>* should be diluted to 2 ml with 0.9% saline or solution for nebuliser, see 6.6.</p><p>Following a single dose an effect may be expected after a few hours. The full therapeutic effect is achieved only after several weeks of treatment. Treatment with Pulmicort is prophylactic therapy with no demonstrated effect on acute disorders.<br />In patients in whom an increased therapeutic effect is desired, in general an increase of the Pulmicort dose is to be recommended in preference to combination treatment with oral corticosteroids on account of the lower risk of systemic side effects.<br />The maintenance dose should be the lowest possible.</p><p><br /><em>Patients dependent on oral steroids:</em><br />When transfer from oral steroids is initiated the patient must be in a relatively stable condition. A high dose of Pulmicort is given in combination with the previously used oral steroid dose for 10 days. After that, the oral dose should be gradually reduced by e.g. 2.5 mg prednisolone or equivalent per month to the lowest possible level. The oral steroid can often be discontinued entirely.</p><p><br />Since budesonide given as Pulmicort suspension for nebuliser is deposited in the lungs with the aid of inspiration, it is important that the patient inhales calmly and with even breaths through the mouthpiece of the nebuliser.</p><p><br />There is no experience of treatment of patients with impaired hepatic or renal function. Since budesonide is eliminated predominantly through metabolism in the liver, increased exposure may be expected in patients with severe cirrhosis of the liver.</p><p><br />A face-mask can be used for children who cannot breathe in through the mouthpiece.</p><p><br /><em>Instruction for correct use of Pulmicort nebuliser suspension:</em><br />Pulmicort nebuliser suspension is inhaled with the aid of a jet nebuliser fitted with a mouthpiece or suitable face-mask.</p><p><br />To minimise the risk of oropharyngeal candida infection, the patient should rinse their mouth out with water after inhaling.</p><p><br /><strong>NOTE!</strong> It is important to instruct the patient/carer to wash the facial skin with water after using the face-mask to prevent facial skin irritation.</p><p>&nbsp;</p><p>Ultrasonic nebulisers must not be used, as they deliver too low a dose of budesonide to the patient.<br />The nebuliser and compressor (propeller unit) must be adjusted so that the majority of the delivered drops of liquid are in the range of 3 to 5 micrometres.<br />An <em>in-vitro</em> study has shown that nebulisers of the types Pari Inhalierboy, Pari Master and Aiolos deliver comparable doses of budesonide.</p><p>The amount of budesonide delivered to a patient varies between 11 and 22 % of the amount administered in the nebuliser, and depends on factors such as<br />- nebulisation time<br />- volume fill<br />- technical performance of the compressor (propeller unit) and the nebuliser<br />- patient&rsquo;s tidal volume<br />- use of face-mask or mouthpiece.</p><p>The air-flow rate through the nebuliser is also important. In order to obtain the maximum available dose of budesonide a flow rate of 5-8 l/min is required. The fill volume should be 2-4 ml.<br />The available dose for small children is maximised by the use of a closely fitting face- mask.</p><p>The single-dose unit must be shaken carefully before being opened.<br />The nebuliser chamber must be cleaned after every administration. Wash the chamber and mouthpiece or face-mask with warm tap water and use a mild detergent.<br />Rinse thoroughly and dry the chamber by connecting it to the compressor or air inlet. See also the nebuliser manufacturer&rsquo;s instructions.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to budesonide or any of the excipients.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Budesonide is not intended for rapid relief of acute episodes of asthma where an inhaled short-acting bronchodilator is required.</p><p>Care is needed in patients transferring from oral steroids, since they may remain at risk of impaired adrenal function for a considerable time. Patients who have required high dose emergency corticosteroid therapy or prolonged treatment at the highest recommended dose of inhaled corticosteroids may also be at risk. These patients may exhibit signs and symptoms of adrenal insufficiency when exposed to severe stress. Additional systemic corticosteroid treatment should be considered during periods of stress or elective surgery.</p><p>Systemic effects of inhaled corticosteroids may occur, particularly at high doses prescribed for prolonged periods. These effects are much less likely to occur than with oral corticosteroids. Possible systemic effects include Cushing&#39;s syndrome, Cushingoid features, adrenal suppression, growth retardation in children and adolescents, decrease in bone mineral density, cataract, glaucoma, and more rarely, a range of psychological or behavioural effects including psychomotor hyperactivity, sleep disorders, anxiety, depression or aggression (particularly in children). It is important therefore that the dose&nbsp;of inhaled corticosteroid is titrated to the lowest dose at which effective control of asthma is maintained.</p><p>Regular monitoring of growth is recommended in children and adolescents receiving long-term treatment with corticosteroids, irrespective of the administration form. The benefits of corticosteroid treatment must be placed in relation to possible risks of inhibition of growth.</p><p>Reduced liver function affects the elimination of corticosteroids, causing lower elimination and higher systemic exposure. Be aware of possible systemic side effects.</p><p>Concomitant use of ketoconazole, itraconazole, HIV protease inhibitors or other potent CYP3A4 inhibitors should be avoided. If this is not possible, the period between treatments should be as long as possible (see also section 4.5).</p><p>Special caution is necessary in patients with active or quiescent pulmonary tuberculosis, and in patients with fungal or viral infections in the airways.</p><p>Oral candidiasis may occur during the therapy with inhaled corticosteroids. This infection may require treatment with appropriate antifungal treatment and in some patients discontinuation of treatment may be necessary (see also section 4.2).</p><p>As with other inhalation therapy, paradoxical bronchospasm may occur with an immediate increase in wheezing after dosing. If this occurs, treatment with inhaled budesonide should be discontinued immediately, the patient assessed and alternative therapy instituted if necessary.</p><p>Patients must be instructed to contact their physician if the effect of the treatment generally diminishes, as repeated inhalations for severe asthma attacks must not delay the initiation of other important therapy. In the event of acute deterioration the treatment should be supplemented with a course of oral steroid for a short period.</p><p>During transfer from oral steroid therapy to Pulmicort, patients may experience previous symptoms such as muscle and joint pain. In these cases a temporary increase of the oral steroid dose may be necessary. If, in isolated cases, fatigue, headache, nausea, vomiting or similar symptoms occur, a generally inadequate steroid effect should be suspected.</p><p>Replacement of systemic steroid treatment by Pulmicort sometimes reveals allergies, e.g. rhinitis and eczema that were previously controlled by the systemic treatment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The metabolism of budesonide is primarily mediated by CYP3A4. Inhibitors of this enzyme, e.g. ketoconazole, itraconazole and HIV-protease inhibitors can therefore increase systemic exposure to budesonide several times (see section 4.4). Since there are no data to support a dosage recommendation, the combination should be avoided. If this is not possible, the period between treatments should be as long as possible, and a reduction of the budesonide dose could also be considered.&nbsp;</p><p>Limited data about this interaction for high-dose inhaled budesonide indicate that marked increases in plasma levels (on average four-fold) may occur if itraconazole 200 mg once daily is administered concomitantly with inhaled budesonide (single dose of<br />1,000 &mu;g).</p><p>Raised plasma concentrations of and increased effects of corticosteroids have been observed in women also treated with oestrogens and contraceptive steroids, but no effect has been observed with budesonide and concomitant intake of low dose combination oral contraceptives.</p><p>Because adrenal function may be suppressed, an ACTH stimulation test for diagnosing pituitary insufficiency might show false results (low values).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Pregnancy:</em><br />Results from approximately 2,000 pregnancies have not revealed any increased risk of malformations as a result of treatment with budesonide. Animal studies have shown that glucocorticosteroids can induce malformations (see 5.3), but this is judged not to be relevant for humans with the recommended dosage.</p><p>Animal studies have also identified an involvement of excess prenatal glucocorticoids in increased risks for intrauterine growth retardation, adult cardiovascular disease and permanent changes in glucocorticoid receptor density, neurotransmitter turnover and behaviour at exposures below the teratogenic dose range.</p><p>During pregnancy the aim must be the lowest effective dose of budesonide while taking account of the risk of a worsening of the asthma.</p><p><em>Lactation:</em></p><p><em>Budesonide is excreted in breast milk. However, at therapeutic doses of Pulmicort pMDI no effects on the suckling child are anticipated. Pulmicort pMDI can be used during breast-feeding.</em></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pulmicort has no influence on the ability to drive and use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>To report any side effect(s):</strong></p><p><strong>&bull; Saudi Arabia:</strong></p><p>- National Pharmacovigilance Center (NPC):<br />o Fax: +966-11-205-7662<br />o Call NPC at :<br />+966-11-2038222 Exts: 2317-2356-2353-2354-2334-2340<br />o Toll free: 8002490000<br />o E-mail: npc.drug@sfda.gov.sa<br />o Website: www.sfda.gov.sa/npc</p><p><strong>&bull; Other GCC states:</strong></p><p>- Please contact the relevant competent authority.</p><p>&nbsp;</p><p>Frequencies are defined as: very common (&ge;1/10); common (&ge;1/100, &lt;1/10); uncommon<br />(&ge;1/1,000, &lt;1/100); rare (&ge;1/10,000, &lt;1/1,000); very rare (&lt;1/10,000).</p><p>&nbsp;</p><table border="1" cellspacing="1" cellpadding="1"><tbody><tr><td><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Table 1</strong></td><td rowspan="1" colspan="2"><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Undesirable drug effects by organ system and frequency</strong></td></tr><tr><td><strong>&nbsp; &nbsp; Organ system</strong></td><td><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Frequency</strong></td><td><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Undesirable drug effect</strong></td></tr><tr><td><strong>Infections and infestations</strong></td><td>Rare</td><td>Candida infections in the oral cavity and throat</td></tr><tr><td><strong>Immune system disorder</strong></td><td>Rare</td><td>Immediate and delayed hypersensitivity reactions* including rash, contact dermatitis, urticaria, angioedema and anaphylactic reaction</td></tr><tr><td><strong>Endocrine system disorders</strong></td><td>Rare</td><td>Signs and symptoms of systemic corticosteroid effects, including adrenal suppression and growth retardation**</td></tr><tr><td><strong>Eye disorders</strong></td><td>Unknown</td><td>Glaucoma<br />Cataract</td></tr><tr><td><strong>Psychiatric disorders</strong></td><td><p>Rare</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Unknown</p></td><td><p>Restlessness</p><p>Nervousness</p><p>Depression<br />Behavioural changes (predominantly in children)</p><p>&nbsp;</p><p>Sleep disorders<br />Anxiety<br />Psychomotor hyperactivity<br />Aggression</p></td></tr><tr><td><strong>Respiratory, thoracic and mediastinal disorders</strong></td><td><p>Common</p><p>&nbsp;</p><p>Rare</p></td><td><p>Cough<br />Throat irritation</p><p>Bronchospasm<br />Dysphonia<br />Hoarseness</p></td></tr><tr><td><strong>Skin and subcutaneous tissue<br />Disorders</strong></td><td>Rare</td><td>Bruising</td></tr></tbody></table><p>On account of the risk of Candida infections in the oropharynx the patient must rinse the mouth with water after every dose.</p><p>* Facial skin irritation, as an example of a hypersensitivity reaction, has occurred in some cases when a nebuliser with a face-mask has been used. To prevent irritation, the facial skin should be washed with water after use of the face-mask.</p><p>There is an increased risk of pneumonia in patients with newly diagnosed COPD starting treatment with inhaled corticosteroids. However, a weighted analysis of 8 pooled clinical trials involving 4,643 COPD patients treated with budesonide and 3,643 patients randomised to non-inhaled corticosteroid treatments sis not demonstrate an increased risk of pneumonia. The results from the first 7 of these 8 trials have been published as a meta-analysis.</p><p><em><strong>** Paediatric population:</strong></em></p><p>Due to the risk of growth retardation in the paediatric population, growth should be monitored regularly, as described in section 4.4.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Acute overdosage with Pulmicort suspension for nebuliser, even in excessive doses, is not expected to be a clinical problem. If it is used chronically in high doses, systemic effects of glucocorticosteroids such as hypercortisolism and adrenal suppression may occur.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Inhalation drugs for obstructive airway diseases. ATC code: R03B A02<br />Budesonide is a glucocorticosteroid with a high local anti-inflammatory effect.</p><p><br />The precise mechanism of action of glucocorticosteroids in the treatment of asthma is not fully understood. Anti-inflammatory effects such as inhibited release of inflammatory mediators and inhibition of cytokine-mediated immune response are probably important. The activity of budesonide, measured as affinity for glucocorticosteroid receptors is approx. 15 times higher than that of prednisolone.</p><p>Budesonide has shown anti-inflammatory effects such as reduced bronchial obstruction during both the early and the late phase of an allergic reaction. Budesonide reduces histamine and metacholine activity in the airways in hyper-reactive patients.</p><p><br />Studies have shown that the earlier the treatment with budesonide is initiated after the onset of asthma, the better is the lung function that can be expected.</p><p><br />Dose-related suppression of plasma and urinary cortisol have been observed in studies in healthy volunteers treated with Pulmicort. At recommended doses, Pulmicort causes a significantly lower effect on the adrenal function than prednisolone 10 mg, as shown by ACTH tests.</p><p>In children over the age of 3 years, no systemic effects have been detected with doses up to 400 micrograms per day. In the range 400-800 micrograms per day biochemical signs of a systemic effect may occur. With daily doses in excess of 800 micrograms such signs are common. This information applies to Pulmicort administered as inhalation spray and inhalation powder.</p><p>Asthma itself, like inhaled corticosteroids, can retard growth. Limited data from long- term studies suggest that most children and adolescents treated with inhaled budesonide will ultimately achieve their adult target height. However, an initial small but transient reduction in growth (approximately 1 cm) has been observed. This generally occurs within the first year of treatment.</p><p>Inhalation therapy with budesonide is effective in preventing effort-induced asthma.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Absorption:</em></p><p>Inhaled budesonide is rapidly absorbed. The peak plasma concentration is reached<br />within 60 minutes after the start of nebulisation and is approximately 4 nmol/litre after a dose of 2 mg. In adults the pulmonary distribution of budesonide, administrated via nebuliser, is approximately 15% of the nominal dose. The systemic bioavailability, following inhalation via jet nebuliser, is also approximately 15% of the nominal dose, of which a small fraction comes from swallowed drug.</p><p><em>Distribution and metabolism</em></p><p>Binding to plasma proteins is approx. 90 %. The volume of distribution is approx.<br />3 l/kg.<br />Budesonide undergoes extensive (&sim; 90%) first pass metabolism in the liver to<br />metabolites with low glucocorticosteroid activity. The glucocorticosteroid activity of the major metabolites, 6&beta;-hydroxybudesonide and 16&alpha;-hydroxyprednisolone, is less than 1% of that of budesonide.</p><p><em>Elimination</em></p><p>Budesonide is eliminated by means of metabolism that is catalysed principally by the enzyme CYP3A4. The metabolites are excreted in the urine in unchanged or conjugated form. Only negligible amounts of unchanged budesonide are recovered in the urine. Budesonide has a high systemic clearance (approx. 1.2 litres/min) and the half-life in plasma after intravenous administration is on average 4 hours. The pharmacokinetics of budesonide are proportional to the dose at clinically relevant doses.</p><p><em>Children:</em></p><p>In 4-6 year old asthmatic children, the maximal plasma concentration occurs within 20 minutes after start of nebulisation and is approximately 2.4 nmol/L after a 1 mg dose. In 4-6 year old asthmatic patients the pulmonary distribution of budesonide, administered via nebuliser, is 6% of the nominal dose, and the systemic availability of budesonide following inhalation via a jet nebuliser (Pari LC Jet Plus with Pari Master compressor) is approximately 6% of the nominal dose. The systemic availability for children is about half of that in adults. Budesonide has a systemic clearance of approximately 0.5 L/min in 4-6 year old asthmatic children. Per kg body weight&nbsp;children have a clearance which is approximately 50% greater than in adults. The half-life of budesonide after inhalation is approximately 2 hours.<br />The exposure (Cmax and AUC) of budesonide following administration of a single 1 mg dose by nebulisation to 4-6 year old children is comparable to that in healthy adults given the same delivered dose by the same nebuliser system.</p><p>The pharmacokinetics of budesonide in patients with impaired renal function are unknown. Exposure to budesonide may be increased in patients with hepatic disease.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In toxicity studies budesonide caused only the expected glucocorticoid effects.Budesonide has not exhibited any genotoxic effects.</p><p><br />In animal reproduction studies, corticosteroids such as budesonide have been shown to induce malformations (cleft palate, skeletal malformations) in various species.<br />However, these animal experimental results do not seem to be relevant in humans at the recommended doses.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Disodium edetate dihydrate Sodium chloride Polysorbate 80<br />Anhydrous citric acid<br />Sodium citrate<br />Water for injections</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pulmicort nebuliser suspension should not be mixed with other drugs than those mentioned under 6.6.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years from manufacture if the single-dose units are stored in the unopened foil envelope. Single-dose units that are stored in an opened envelope must be used within 3 months. The contents of an opened single-dose unit must be used within 12 hours. Observe that if only 1 ml has been used the remaining volume is not sterile.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C. Do not freeze.<br />The single-dose units should be stored in an upright position, to protect the suspension from sedimentation. After an envelope has been opened the single-dose units must be stored in a sealed envelope. Sensitive to light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>20 single-dose units made of LD-polyethylene ( 2 ml ):<br />The single-dose units are packed in fives in an aluminium foil envelope. One package contains four aluminium foil envelopes. Each single-dose unit contains 2 ml suspension.<br />For the strengths 0.25 and 0.5 mg/ml there is a line indicating 1 ml when the single-dose units are held upside down.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pulmicort nebuliser suspension can be mixed with sodium chloride solution 9 mg/ml<br />(0.9 %) and/or with nebuliser solutions containing terbutaline, salbutamol, fenoterol, acetylcysteine, sodium cromoglicate or ipratropium bromide. The mixture should be used within 30 minutes.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                AstraZeneca AB
SE-151 85 Södertälje
Södertälje
Sweden
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                05/05/2014
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>